J2 Health, a New York-based B2B healthcare SaaS company, raised a $4.5 million seed investment round.
The round was led by New York-based venture capital firms Primary Ventures, Tiger Global, and BoxGroup to enable healthcare organizations to optimize provider network performance. Industry leaders including Mario Schlosser, CEO of Oscar Health, also participated in the round.
J2 seeks to capitalize on significant early momentum by fueling product development, expanding its data and analytics offerings, and growing its team.
Company: J2 Health Inc.
Round: Seed Round
Funding Month: March 2022
Lead Investors: Primary Ventures, Tiger Global and BoxGroup
Additional Investors: Mario Schlosser
Company Website: http://www.j2health.com/
Software Category: Network Management and Analytics System
About the Company: Founded in 2020, J2 Health Inc., whose name was inspired by the Portuguese word “Jeito” or “way”, provides a systematic way of evaluating healthcare network quality and prioritizing the highest-value improvements. Its adaptive interface and visualization tools help organizations connect the dots from strategy to execution. J2 aims to enable healthcare organizations to optimize provider network performance via a systematic way of evaluating network quality and identifying improvements. J2 Health’s vision is to empower organizations to identify the right providers for their networks.